통합검색
한의약융합데이터 콘텐츠 바로가기
| 전체보기 학술정보센터 (14)건 |
| 연구자 인터뷰 |
| KMCRIC TV |
| 학회 참관기 |
| 전체보기 한의약융합데이터센터 (8765)건 | ||||
| 근거중심한의약 DB | ||||
| [무작위배정 비교임상연구] J Ginseng Res. 2022 Preventive effects of ginseng against atherosclerosis and subsequent ischemic stroke: A randomized controlled trial (PEGASUS trial). | ||||
| [무작위배정 비교임상연구] Medicine (Baltimore). 2017 Beneficial effects of Fu-Zheng-Qu-Zhuo oral liquid combined with standard integrated therapy in patients with chronic kidney disease (stage 3-4): A randomized placebo-controlled clinical trial. | ||||
| 약물상호작용 DB | ||||
[한약-검사지표 상호작용]
In human trials, measured lactate levels were similar between creatine and placebo [116;117] or lacked significant changes [78;118;29;119;12;120;13;99;
...
임상 연구에서 측정된 젖산 수치는 크레아틴 투여군과 플라시보군에서 서로 유사했으며 [116;117] 유의한 차이가 없었다[78;118;29;119;12;120;13;99;71;72;80;344;121]. 잘 통제된 임산 연구에서,...
|
||||
|
[한약-양약 상호작용]
In a randomized, equivalence human trial, favorable effects on clinical symptoms were observed with phosphocreatine alone (when combined with digoxin these improvements were additive), and a significant 40%
...
무작위 임상시험에서, 포스포크레아틴을 단독 사용했을 경우, 임상적인 징후에 긍정적인 효과가 관찰되었으며 디곡신(digoxin)과 병용하는 경우 더욱 효과적이었다. 그리고, 디곡신 + 이뇨제 + 포스포크레아틴의...
|
||||
| 생약 up-to-date | ||||
|
||||
|
| 전체보기 사이언스센터 (10)건 |
| 한의약 과학 한마당 |
| 연구자 인터뷰 |
| KMCRIC TV |
| 학회 참관기 |
| 근거중심한의약 DB |
| [무작위배정 비교임상연구] J Ginseng Res. 2022 Preventive effects of ginseng against atherosclerosis and subsequent ischemic stroke: A randomized controlled trial (PEGASUS trial). |
| [무작위배정 비교임상연구] Medicine (Baltimore). 2017 Beneficial effects of Fu-Zheng-Qu-Zhuo oral liquid combined with standard integrated therapy in patients with chronic kidney disease (stage 3-4): A randomized placebo-controlled clinical trial. |
| 약물상호작용 DB | ||||
|
[한약-검사지표 상호작용]
In human trials, measured lactate levels were similar between creatine and placebo [116;117] or lacked significant changes [78;118;29;119;12;120;13;99;71;72;80;344;121]. In a controlled trial, the lactate threshold rose significantly following creatine supplementation [122]. Increased lactate has been reported in a controlled trial [95]. Decreased lactate has been reported in controlled trials [123;79;124]. In humans, plasma lactate increased by 20.8% in a randomized controlled trial [5] and also increased significantly when combined with caffeine [106].
임상 연구에서 측정된 젖산 수치는 크레아틴 투여군과 플라시보군에서 서로 유사했으며 [116;117] 유의한 차이가 없었다[78;118;29;119;12;120;13;99;71;72;80;344;121]. 잘 통제된 임산 연구에서,...
|
||||
|
[한약-양약 상호작용]
In a randomized, equivalence human trial, favorable effects on clinical symptoms were observed with phosphocreatine alone (when combined with digoxin these improvements were additive), and a significant 40% increase in exercise tolerance in the digoxin + diuretics + phosphocreatine group was observed [31]. Both the digoxin + creatine and the creatine groups showed a significant decrease in frequency of angina attacks compared to the digoxin-only group (44.4% vs. 61%, p<0.05). The amount of nitroglycerin consumed decreased significantly in the digoxin + creatine and creatine-only groups compared to placebo (41.2% vs. 60%, p<0.05). Various clinical studies, case series, and randomized trials reported that creatine supplementation may have use in congestive heart failure [31;32;33;34;35;36;37]; therefore, additive effects may be possible with heart failure medications.
무작위 임상시험에서, 포스포크레아틴을 단독 사용했을 경우, 임상적인 징후에 긍정적인 효과가 관찰되었으며 디곡신(digoxin)과 병용하는 경우 더욱 효과적이었다. 그리고, 디곡신 + 이뇨제 + 포스포크레아틴의...
|
| 생약 up-to-date |
|
|
|
|
| 생활 속 한의 |
| 한의약 과학 한마당 |